-
Role of mucosal immunity in herpes simplex virus infection.
J Immunol. 1998 Jun 15;160(12):5998-6003
PMID: 9637514
-
CD4(+) T cell-mediated control of a gamma-herpesvirus in B cell-deficient mice is mediated by IFN-gamma.
Proc Natl Acad Sci U S A. 1999 Apr 27;96(9):5135-40
PMID: 10220431
-
Control of murine gammaherpesvirus infection is independent of NK cells.
Eur J Immunol. 2005 Oct;35(10):2956-61
PMID: 16134085
-
Influence of mucosal and parenteral immunization with a replication-defective mutant of HSV-2 on immune responses and protection from genital challenge.
Virology. 1998 Mar 30;243(1):178-87
PMID: 9527927
-
Long-term MHC class II presentation of the EBV lytic protein BHRF1 by EBV latently infected b cells following capture of BHRF1 antigen.
J Immunol. 2005 Dec 15;175(12):7939-46
PMID: 16339529
-
CD4+ T-cell responses are required for clearance of West Nile virus from the central nervous system.
J Virol. 2006 Dec;80(24):12060-9
PMID: 17035323
-
Antibody vs. HIV in a clash of evolutionary titans.
Proc Natl Acad Sci U S A. 2005 Oct 18;102(42):14943-8
PMID: 16219699
-
Early resolution of herpes simplex virus type 2 infection of the murine genital tract involves stimulation of genital parenchymal cells by gamma interferon.
J Virol. 2007 Jan;81(1):423-6
PMID: 17065206
-
Immunology of tuberculosis.
Annu Rev Immunol. 2001;19:93-129
PMID: 11244032
-
Thymidine kinase-negative herpes simplex virus mutants establish latency in mouse trigeminal ganglia but do not reactivate.
Proc Natl Acad Sci U S A. 1989 Jun;86(12):4736-40
PMID: 2543985
-
Mice can recover from pulmonary influenza virus infection in the absence of class I-restricted cytotoxic T cells.
J Immunol. 1992 Jan 1;148(1):212-7
PMID: 1530795
-
Functional role of type I and type II interferons in antiviral defense.
Science. 1994 Jun 24;264(5167):1918-21
PMID: 8009221
-
Differential roles of B cells and IFN-gamma-secreting CD4(+) T cells in innate and adaptive immune control of genital herpes simplex virus type 2 infection in mice.
J Gen Virol. 2001 Apr;82(Pt 4):845-853
PMID: 11257190
-
Genetic identification of a portion of the herpes simplex virus ICP8 protein required for DNA-binding.
Virology. 1988 Apr;163(2):319-29
PMID: 2833010
-
The lack of RNA-dependent protein kinase enhances susceptibility of mice to genital herpes simplex virus type 2 infection.
Immunology. 2006 Aug;118(4):520-6
PMID: 16895559
-
Therapeutic B cell depletion impairs adaptive and autoreactive CD4+ T cell activation in mice.
Proc Natl Acad Sci U S A. 2007 Dec 26;104(52):20878-83
PMID: 18093919
-
Herpes simplex virus type 2-mediated disease is reduced in mice lacking RNase L.
Virology. 2007 Apr 10;360(2):322-8
PMID: 17157346
-
CD8alpha+ and CD11b+ dendritic cell-restricted MHC class II controls Th1 CD4+ T cell immunity.
J Immunol. 2003 Nov 15;171(10):5077-84
PMID: 14607905
-
Neutralizing antiviral B cell responses.
Annu Rev Immunol. 1997;15:235-70
PMID: 9143688
-
T-cell-mediated mechanisms involved in resolution of genital herpes simplex virus type 2 (HSV-2) infection of mice.
J Reprod Immunol. 2004 Apr;61(2):115-27
PMID: 15063634
-
Insights into CD4+ memory T cells following Leishmania infection.
Trends Parasitol. 2005 Aug;21(8):347-50
PMID: 15967724
-
Inhibition of autoimmune diabetes by Fas ligand: the paradox is solved.
J Immunol. 2000 Mar 15;164(6):2931-6
PMID: 10706679
-
Dendritic cells maximize the memory CD8 T cell response to infection.
Immunity. 2005 May;22(5):561-70
PMID: 15894274
-
Incorporation of the green fluorescent protein into the herpes simplex virus type 1 capsid.
J Virol. 1998 Sep;72(9):7563-8
PMID: 9696854
-
Vaginal submucosal dendritic cells, but not Langerhans cells, induce protective Th1 responses to herpes simplex virus-2.
J Exp Med. 2003 Jan 20;197(2):153-62
PMID: 12538655
-
Cutting Edge: Plasmacytoid dendritic cells provide innate immune protection against mucosal viral infection in situ.
J Immunol. 2006 Dec 1;177(11):7510-4
PMID: 17114418
-
Essential roles of perforin in antigen-specific cytotoxicity mediated by human CD4+ T lymphocytes: analysis using the combination of hereditary perforin-deficient effector cells and Fas-deficient target cells.
J Immunol. 2003 Feb 15;170(4):2205-13
PMID: 12574394
-
CD4(+) T cell subsets during virus infection. Protective capacity depends on effector cytokine secretion and on migratory capability.
J Exp Med. 2000 Jun 19;191(12):2159-70
PMID: 10859340
-
Herpes simplex virus type 1 targets the MHC class II processing pathway for immune evasion.
J Immunol. 2003 Sep 15;171(6):3075-83
PMID: 12960333
-
Clearance of an influenza A virus by CD4+ T cells is inefficient in the absence of B cells.
J Virol. 1998 Jan;72(1):882-5
PMID: 9420305
-
Liposome mediated depletion of macrophages: mechanism of action, preparation of liposomes and applications.
J Immunol Methods. 1994 Sep 14;174(1-2):83-93
PMID: 8083541
-
T lymphocytes are required for protection of the vaginal mucosae and sensory ganglia of immune mice against reinfection with herpes simplex virus type 2.
J Immunol. 1998 Jun 15;160(12):6093-100
PMID: 9637526
-
Interferon-gamma enhances resolution of herpes simplex virus type 2 infection of the murine genital tract.
Virology. 1997 Mar 3;229(1):259-68
PMID: 9123869
-
Vaginal epithelial dendritic cells renew from bone marrow precursors.
Proc Natl Acad Sci U S A. 2007 Nov 27;104(48):19061-6
PMID: 18006657
-
Effector CD4+ T-cell involvement in clearance of infectious herpes simplex virus type 1 from sensory ganglia and spinal cords.
J Virol. 2008 Oct;82(19):9678-88
PMID: 18667492
-
Suppression of proteoglycan-induced arthritis by anti-CD20 B Cell depletion therapy is mediated by reduction in autoantibodies and CD4+ T cell reactivity.
J Immunol. 2008 Apr 1;180(7):4994-5003
PMID: 18354225
-
The role of gamma interferon in immune resistance to vaginal infection by herpes simplex virus type 2 in mice.
Virology. 1999 Jun 5;258(2):282-94
PMID: 10366565
-
Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis.
Nature. 1992 Mar 26;356(6367):314-7
PMID: 1372394
-
Pathogenetic effector function of CD4-positive T helper 1 cells in hepatitis B virus transgenic mice.
J Immunol. 1997 Aug 15;159(4):2001-8
PMID: 9257867
-
Effector cells of both nonhemopoietic and hemopoietic origin are required for interferon (IFN)-gamma- and tumor necrosis factor (TNF)-alpha-dependent host resistance to the intracellular pathogen, Toxoplasma gondii.
J Exp Med. 1999 Apr 5;189(7):1083-92
PMID: 10190899
-
Protection against influenza virus infection by intranasal vaccine with surf clam microparticles (SMP) as an adjuvant.
J Med Virol. 2006 Jul;78(7):954-63
PMID: 16721854
-
Mucosal immunity to herpes simplex virus type 2 infection in the mouse vagina is impaired by in vivo depletion of T lymphocytes.
J Virol. 1998 Apr;72(4):2677-85
PMID: 9525585
-
Noncytolytic control of viral infections by the innate and adaptive immune response.
Annu Rev Immunol. 2001;19:65-91
PMID: 11244031
-
CD4 T cell-mediated protection from lethal influenza: perforin and antibody-mediated mechanisms give a one-two punch.
J Immunol. 2006 Sep 1;177(5):2888-98
PMID: 16920924
-
Mucosal and systemic immune responses to a human immunodeficiency virus type 1 epitope induced upon vaginal infection with a recombinant influenza A virus.
J Virol. 2004 Jan;78(2):1020-5
PMID: 14694134
-
Clearance of herpes simplex virus type 2 by CD8+ T cells requires gamma interferon and either perforin- or Fas-mediated cytolytic mechanisms.
J Virol. 2005 Dec;79(23):14546-54
PMID: 16282454